Results 121 to 130 of about 4,251 (181)

BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders. [PDF]

Biomolecules
Duminuco A, De Luca P, Stanzione G, Caruso LA, Lavenia G, Scarso S, Garibaldi B, Palumbo FE, Vetro C, Palumbo GA.   +9 more
europepmc   +1 more source

Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data. [PDF]

J Manag Care Spec Pharm
Fitzgerald L, Ghosh S, Khan W, Bokun A, Lax A, Mu F, Cook EE, Chen J, Chen G, Wu E, Lin Y, Shi L, Qureshi ZP, Graf SA.   +13 more
europepmc   +1 more source

Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. [PDF]

Clin Exp Med
D'Amato M, Rapolla CM, Benedetti E, Bocchia M, Capochiani E, Carlomagno G, Ciofini S, Giachetti R, Maestrini G, Moretti S, Nasso D, Papini G, Pirrotta MT, Simonetti F, Santini S, Vannucchi A, Galimberti S, Sanna A.   +17 more
europepmc   +1 more source

Bruton tyrosine kinase inhibitors in combination with chemoimmunotherapy is an effective treatment for patients with Richter's syndrome. [PDF]

Leuk Res Rep
Meier T, Huynh G, Ayala E, Tun HW, Iqbal M.   +4 more
europepmc   +1 more source

First-line treatment for CLL in the era of targeted therapy. [PDF]

Blood Cancer J
Davids MS, Stilgenbauer S, Tam CS.
europepmc   +1 more source

Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis. [PDF]

Blood Adv
Srisurapanont K, Meejun T, Manothummetha K, Li LX, Baddley JW, Schulz CA, Dioverti-Prono MV, Zhang SX, Avery RK, Kates OS, Permpalung N.   +10 more
europepmc   +1 more source

Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Hetta HF, Salama A, Aljuaid TA, Mojmami YT, Alotibi RS, Alqabaly AM, Aldosari NA, Alshahri SA, Asiri WIA, Alamri RS, Alanazi FA, Alenazi MSA, Albuhayri MH, Ramadan YN, Sayad R.   +14 more
europepmc   +1 more source

Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients. [PDF]

Future Oncol
Dingli D, De Nigris E, Leng S, Farooqui MZH, Yapici HO, Weimer I, Jiao W, Hyatt H, Zhang X, Lodaya K, Obeng-Kusi M.   +10 more
europepmc   +1 more source

Leukemic penile ulcer as the presenting symptom of chronic lymphatic leukemia. [PDF]

J Surg Case Rep
Sandhu HS, Chandra S, Joshi S.
europepmc   +1 more source

Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report. [PDF]

Cureus
Al-Shaker AN, Agarwal A, Saeed MT, Marney Z.   +3 more
europepmc   +1 more source